Kanaph Therapeutics is based in Seoul, South Korea. It has raised $73M in total funding. Latest round: Series C.
Kanaph Therapeutics is based in Seoul, South Korea. Kanaph Therapeutics has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for Kanaph Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Lotte Biologics, GC Pharma, InterVest, Premier Partners, Solidus Investment, Daily Partners and 3 others. 9 distinct backers are named across the disclosed rounds.
Round data for Kanaph Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Seoul and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026